JAM2 Antibody

Code CSB-PA011936LA01HU
Size US$166
Order now
Image
  • Western blot
    All lanes: JAM2 antibody at 2µg/ml + Recombinant Junctional adhesion molecule B protein
    Secondary
    Goat polyclonal to rabbit IgG at 1/10000 dilution
    Predicted band size: 34, 30, 35 kDa
    Observed band size: 23 kDa
The Latest Promotion Free Antibody trial simple
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Full Product Name
Rabbit anti-Homo sapiens (Human) JAM2 Polyclonal antibody
Uniprot No.
Target Names
JAM2
Alternative Names
C21orf43 antibody; CD 322 antibody; CD322 antibody; CD322 antigen antibody; JAM 2 antibody; JAM B antibody; JAM IT/VE JAM antibody; JAM; vascular endothelial antibody; JAM-2 antibody; JAM-B antibody; JAM2 antibody; JAM2_HUMAN antibody; JAMB antibody; Jcam2 antibody; Junction adhesion molecule 2 antibody; Junction adhesion molecule B antibody; Junctional adhesion molecule 2 antibody; Junctional adhesion molecule B antibody; PRO 245 antibody; PRO245 antibody; Vascular endothelial junction associated molecule antibody; Vascular endothelial junction-associated molecule antibody; VE JAM antibody; VE-JAM antibody; VEJAM antibody
Raised in
Rabbit
Species Reactivity
Human
Immunogen
Recombinant Human Junctional adhesion molecule B protein (29-238AA)
Immunogen Species
Homo sapiens (Human)
Conjugate
Non-conjugated

The JAM2 Antibody (Product code: CSB-PA011936LA01HU) is Non-conjugated. For JAM2 Antibody with conjugates, please check the following table.

Available Conjugates
Conjugate Product Code Product Name Application
HRP CSB-PA011936LB01HU JAM2 Antibody, HRP conjugated ELISA
FITC CSB-PA011936LC01HU JAM2 Antibody, FITC conjugated
Biotin CSB-PA011936LD01HU JAM2 Antibody, Biotin conjugated ELISA
Clonality
Polyclonal
Isotype
IgG
Purification Method
>95%, Protein G purified
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
Form
Liquid
Tested Applications
ELISA, WB
Recommended Dilution
Application Recommended Dilution
WB 1:1000-1:5000
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Junctional adhesion protein that mediates heterotypic cell-cell interactions with its cognate receptor JAM3 to regulate different cellular processes. Plays a role in homing and mobilization of hematopoietic stem and progenitor cells within the bone marrow. At the surface of bone marrow stromal cells, it contributes to the retention of the hematopoietic stem and progenitor cells expressing JAM3. Plays a central role in leukocytes extravasation by facilitating not only transmigration but also tethering and rolling of leukocytes along the endothelium. Tethering and rolling of leukocytes are dependent on the binding by JAM2 of the integrin alpha-4/beta-1. Plays a role in spermatogenesis where JAM2 and JAM3, which are respectively expressed by Sertoli and germ cells, mediate an interaction between both cell types and play an essential role in the anchorage of germ cells onto Sertoli cells and the assembly of cell polarity complexes during spermatid differentiation. Also functions as an inhibitory somatodendritic cue that prevents the myelination of non-axonal parts of neurons. During myogenesis, it is involved in myocyte fusion. May also play a role in angiogenesis.
Gene References into Functions
  1. this review briefly focuses on what is currently known about the structure, function, and mechanism of JAM-B, with particular emphasis on cancer. [review] PMID: 27121546
  2. JAM-2 may function as a putative tumour suppressor in the progression and metastasis of colorectal cancer PMID: 26782073
  3. This study showed thatJAM2 (rs2829841; intronic), associated with Alzheimer disease. PMID: 25649652
  4. Function of Jam-B/Jam-C interaction in homing and mobilization of human and mouse hematopoietic stem and progenitor cells. PMID: 24357068
  5. These data brought new evidences for the role of JAM2 and JAM3 in progression of gastric adenocarcinoma PMID: 23277282
  6. role as an adhesive ligand for interacting with a variety of immune cell types PMID: 11823489
  7. interacts with alpha4beta1; Facilitation by JAM3 PMID: 12070135
  8. Results suggest a role for junctional adhesion molecule-2 (JAM-2) in facilitating transmigration in endothelial cells PMID: 12476045
  9. Examine JAM-2 expression in normal/inflammed lymphatic endothelium. PMID: 17822725
  10. Discovery as ligand for the integrin alpha4beta1 PMID: 12070135
  11. Cloning and discovery as adhesion receptor for T cells PMID: 10945976

Show More

Hide All

Subcellular Location
Cell membrane; Single-pass type I membrane protein. Cell junction. Cell junction, tight junction.
Protein Families
Immunoglobulin superfamily
Tissue Specificity
Highly expressed in heart, placenta, lung, foreskin and lymph node. Prominently expressed on high endothelial venules and also present on the endothelia of other vessels (at protein level). Also expressed in the brain in the caudate nuclei.
Database Links

HGNC: 14686

OMIM: 606870

KEGG: hsa:58494

STRING: 9606.ENSP00000420419

UniGene: Hs.517227

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*